Compound ID | 782
EP 1562
Class: Macrolide
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Protein synthesis inhibitor |
| Target Pathogen: | Active against drug resistant pathogens causing respiratory tract infection |
| Description: | A 6,11-O-bridged oxime macrolide; Wang G, Niu D, Vo N, et al. Structure-activity relationship of novel 6, 11- bridged oxime ketolides with excellent activities against drug resistance pathogens and good pharmokinetic properties. 43rd-ICAAC 2003;245 |
| Institute where first reported: | Enanta Pharmaceuticals, USA |
| Year first mentioned: | 2003 |
| Development status: | Experimental |
| External links: | |
| Citation: | https://doi.org/10.1128/aac.49.1.281-288.2005 |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.